ANVS vs REGN: Which Stock is Better?
Side-by-side comparison of Annovis Bio Inc and Regeneron Pharmaceuticals Inc in 2026
ANVS
Annovis Bio Inc
$1.76
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | ANVS | REGN | Winner |
|---|---|---|---|
| Market Cap | $50.64M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 44.6% | REGN |
Analyze ANVS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANVS or REGN a better investment?
Comparing ANVS and REGN: Annovis Bio Inc has a market cap of $50.64M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANVS and REGN?
ANVS (Annovis Bio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANVS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANVS or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for ANVS.
Which company is more profitable: ANVS or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for ANVS.
Which is the larger company: ANVS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $50.64M for ANVS.
Should I buy ANVS or REGN in 2026?
Both ANVS and REGN have investment merit. ANVS trades at $1.76 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANVS and REGN stock?
Key differences: Market Cap ($50.64M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).